Treatment with Iberdomide Enhances Antitumor Function of the Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel)

Qin, J; Jiang, Y; Barajas, B; Kasibhatla, S; Ports, M

MOLECULAR THERAPY, 2020; 28 (4): 499